Tracer library / [18F]ApaScan
[18F]ApaScan
Also written as [18F]ApaScan
- Radionuclide
- F-18 t½ 109.77 min
- Modality
- PET
- Production route
- —
- Stage
- Preclinical
- Syntheses indexed
- 1
What it is
- Compound class
- 6-chloro-5-fluoro-1-(2-[18F]fluoroethyl)-2-(pyridin-3-yl)-1H-benzo[d]imidazole, a fluorine-18 labeled benzimidazole PET tracer
- Target / mechanism
- CYP11B2 (aldosterone synthase) PMID 41830677
- Clinical application
- Aldosterone-producing adenomas in patients with primary aldosteronism PMID 41830677
- Theranostic pair
- —
Published syntheses
| Module | Cassette | Purification | Yield % | RCP % | Precursor / supplier | Source |
|---|---|---|---|---|---|---|
| FASTlab GE HealthCare | — | HPLC | 29.2 ± 0.5% not corrected | >99% | — | 41830677 2026 Nucl Med Biol The automated radiosynthesis process was optimized on a cassette-based FASTlab module integrated with preparative HPLC to afford the final formulation (ca. 5% ethanol). - The automated radiosynthesis achieved a non-decay-corrected yield of 29.2 ± 0.5% |
Need this precursor?We can point you to suppliers for [18F]ApaScan, or handle the enquiry for you.
Get in touchQuality control Preliminary - inferred from compound class
- Ph. Eur. monograph
- not verified No Ph. Eur. check is recorded for this entry.
- USP monograph
- not verified No USP check is recorded for this entry.
How this set was arrived at. base set per Ph. Eur. general monograph 0125 (rule); organic-phase radiosynthesis assumed from isotope/compound class, no synthesis data confirming it -> GC residual solvents (preliminary); conventional nucleophilic 18F-fluorination assumed from isotope/compound class, no synthesis data confirming K222 use -> Kryptofix test (preliminary)
Tests listed by reference only. Monograph texts are copyrighted and are not reproduced here. How these are derived
Setting up quality control?We can help you scope the equipment needed to release [18F]ApaScan.
Get in touchNotes
Added from reverse module search (stage 6); 1 article(s) with F-18. | Stage 28: added indication(s) end-adrenal from consolidated missing-rubric review. | Stage 30 (2026-09-18): Stage was 'preclinical (preparing for first-in-human studies)'; normalised to 'Preclinical', original wording kept here.